Trial · NCT05214573
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Revascularization Procedure | Cardiac disorders | Aims 1, 2B, and 3 Groups | 42,514 | 386,276 | |
| other | Revascularization Procedure | Cardiac disorders | Aim 2A Group | 0 | 25 | |
| other | Lower Extremity Complication | Injury, poisoning and procedural complications | Aims 1, 2B, and 3 Groups | 21,466 | 386,276 | |
| other | Lower Extremity Complication | Injury, poisoning and procedural complications | Aim 2A Group | 0 | 25 | |
| other | Treatment for Retinopathy | Eye disorders | Aims 1, 2B, and 3 Groups | 4,934 | 386,276 | |
| other | Treatment for Retinopathy | Eye disorders | Aim 2A Group | 0 | 25 | |
| serious | Acute MI | Cardiac disorders | Aims 1, 2B, and 3 Groups | 11,372 | 386,276 | |
| serious | Acute MI | Cardiac disorders | Aim 2A Group | 0 | 25 | |
| serious | Acute Stroke | Nervous system disorders | Aims 1, 2B, and 3 Groups | 10,647 | 386,276 | |
| serious | Acute Stroke | Nervous system disorders | Aim 2A Group | 0 | 25 | |
| serious | Heart Failure Hospitalization | Cardiac disorders | Aims 1, 2B, and 3 Groups | 10,455 | 386,276 | |
| serious | Heart Failure Hospitalization | Cardiac disorders | Aim 2A Group | 0 | 25 | |
| serious | Chronic Kidney Disease Stage 5 or ESKD | Renal and urinary disorders | Aims 1, 2B, and 3 Groups | 9,216 | 386,276 | |
| serious | Chronic Kidney Disease Stage 5 or ESKD | Renal and urinary disorders | Aim 2A Group | 25 | ||
| serious | Hypoglycemia | Metabolism and nutrition disorders | Aims 1, 2B, and 3 Groups | 4,282 | 386,276 | |
| serious | Hypoglycemia | Metabolism and nutrition disorders | Aim 2A Group | 25 | ||
| serious | Amputation | Injury, poisoning and procedural complications | Aims 1, 2B, and 3 Groups | 4,661 | 386,276 | |
| serious | Amputation | Injury, poisoning and procedural complications | Aim 2A Group | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05214573/events